| Items | Drug Registration information |
|---|---|
| ID | 329 |
| No | 329 |
| Brand Name | LIPIDUCE-20 |
| Ingredients | ATORVASTATIN CALCIUM 21.70 MG EQ.TO ATORVASTATIN 20 MG |
| Dosage Form | TABLET |
| Primary Packaging | BLISTERPACK |
| Storage | |
| Shelf Life | 3 YEARS |
| Pack Size | BOX OF 3 X 10'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | AS AN ADJUNCT THERAPY TO DIET TO REDUCE ELEVATED TOTAL, LDL-CHOLESTEROL, APOLIPOPROTEINE B, TRIGLYCERIDES AND INCREASE HDL-CHOLESTEROL IN PATIENT WITH PRIMARY HYPERCHOLESTEROLEMIA ( HETEROZYGOUS FAMILIAL AND NONFAMILIAL), COMBINED HYPERLIPIDEMIA (FREDRICKSON TYPES IIA AND IIB), PRIMARY DYSETALIPOPROTEINEMIA |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE COLOURED FILM COATED OVAL SHAPED TABLETS, SHALLOW CONVEX FACES, PLAIN ON BOTH SIDE. |
| Note | |
| License Owner | BMS PHARMA SOLE CO.,LTD |
| Manufacturer | HOVID BHD |
| Country | MALAYSIA |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 04 I 4689/19 |
| FDD Registration Date | 07/07/2025 |
| Expiry Date | 06/07/2030 |